Calamos Advisors’s Axsome Therapeutics AXSM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-12,808
| Closed | -$1.08M | – | 867 |
|
|
2024
Q4 | $1.08M | Buy |
+12,808
| New | +$1.08M | ﹤0.01% | 628 |
|
|
2023
Q3 | – | Sell |
-12,755
| Closed | -$917K | – | 906 |
|
|
2023
Q2 | $917K | Buy |
+12,755
| New | +$917K | ﹤0.01% | 688 |
|
|
2020
Q3 | – | Sell |
-8,446
| Closed | -$695K | – | 685 |
|
|
2020
Q2 | $695K | Buy |
+8,446
| New | +$695K | ﹤0.01% | 645 |
|